Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Next Generation Sequencers (NGS) Market

4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
    5.1. Technological Advancements
    5.2. Regulatory Scenario
    5.3. COVID-19 Pandemic Impact on Industry

6. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product, 2017–2031
        6.3.1. Benchtop Sequencers
        6.3.2. Floor Standing Sequencers
    6.4. Market Attractiveness Analysis, by Product

7. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Oncology
        7.3.2. Infectious Diseases
        7.3.3. Reproductive Health
        7.3.4. Metagenomics, Epidemiology, and Drug Development
        7.3.5. Consumer Genomics
    7.4. Market Attractiveness Analysis, by Application

8. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Technology
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Technology, 2017–2031
        8.3.1. WGS
        8.3.2. Whole Exome Sequencing
        8.3.3. Targeted Sequencing & Resequencing
    8.4. Market Attractiveness Analysis, by Technology

9. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Academic Research
        9.3.2. Clinical Research
        9.3.3. Hospitals & Clinics
        9.3.4. Pharma & Biotech Entities
        9.3.5. Others
    9.4. Market Attractiveness Analysis, by End-user

10. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region

11. North America Next Generation Sequencers (NGS) Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017–2031
        11.2.1. Benchtop Sequencers
        11.2.2. Floor Standing Sequencers
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Oncology
        11.3.2. Infectious Diseases
        11.3.3. Reproductive Health
        11.3.4. Metagenomics, Epidemiology, and Drug Development
        11.3.5. Consumer Genomics
    11.4. Market Value Forecast, by Technology, 2017–2031
        11.4.1. WGS
        11.4.2. Whole Exome Sequencing
        11.4.3. Targeted Sequencing & Resequencing
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Academic Research
        11.5.2. Clinical Research
        11.5.3. Hospitals & Clinics
        11.5.4. Pharma & Biotech Entities
        11.5.5. Others
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product
        11.7.2. By Application
        11.7.3. By Technology
        11.7.4. By End-user
        11.7.5. By Country

12. Europe Next Generation Sequencers (NGS) Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017–2031
        12.2.1. Benchtop Sequencers
        12.2.2. Floor Standing Sequencers
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Oncology
        12.3.2. Infectious Diseases
        12.3.3. Reproductive Health
        12.3.4. Metagenomics, Epidemiology, and Drug Development
        12.3.5. Consumer Genomics
    12.4. Market Value Forecast, by Technology, 2017–2031
        12.4.1. WGS
        12.4.2. Whole Exome Sequencing
        12.4.3. Targeted Sequencing & Resequencing
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Academic Research
        12.5.2. Clinical Research
        12.5.3. Hospitals & Clinics
        12.5.4. Pharma & Biotech Entities
        12.5.5. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Product
        12.7.2. By Application
        12.7.3. By Technology
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017–2031
        13.2.1. Benchtop Sequencers
        13.2.2. Floor Standing Sequencers
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Oncology
        13.3.2. Infectious Diseases
        13.3.3. Reproductive Health
        13.3.4. Metagenomics, Epidemiology, and Drug Development
        13.3.5. Consumer Genomics
    13.4. Market Value Forecast, by Technology, 2017–2031
        13.4.1. WGS
        13.4.2. Whole Exome Sequencing
        13.4.3. Targeted Sequencing & Resequencing
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Academic Research
        13.5.2. Clinical Research
        13.5.3. Hospitals & Clinics
        13.5.4. Pharma & Biotech Entities
        13.5.5. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Product
        13.7.2. By Application
        13.7.3. By Technology
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017–2031
        14.2.1. Benchtop Sequencers
        14.2.2. Floor Standing Sequencers
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Oncology
        14.3.2. Infectious Diseases
        14.3.3. Reproductive Health
        14.3.4. Metagenomics, Epidemiology, and Drug Development
        14.3.5. Consumer Genomics
    14.4. Market Value Forecast, by Technology, 2017–2031
        14.4.1. WGS
        14.4.2. Whole Exome Sequencing
        14.4.3. Targeted Sequencing & Resequencing
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Academic Research
        14.5.2. Clinical Research
        14.5.3. Hospitals & Clinics
        14.5.4. Pharma & Biotech Entities
        14.5.5. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Product
        14.7.2. By Application
        14.7.3. By Technology
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product, 2017–2031
        15.2.1. Benchtop Sequencers
        15.2.2. Floor Standing Sequencers
    15.3. Market Value Forecast, by Application, 2017–2031
        15.3.1. Oncology
        15.3.2. Infectious Diseases
        15.3.3. Reproductive Health
        15.3.4. Metagenomics, Epidemiology, and Drug Development
        15.3.5. Consumer Genomics
    15.4. Market Value Forecast, by Technology, 2017–2031
        15.4.1. WGS
        15.4.2. Whole Exome Sequencing
        15.4.3. Targeted Sequencing & Resequencing
    15.5. Market Value Forecast, by End-user, 2017–2031
        15.5.1. Academic Research
        15.5.2. Clinical Research
        15.5.3. Hospitals & Clinics
        15.5.4. Pharma & Biotech Entities
        15.5.5. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Product
        15.7.2. By Application
        15.7.3. By Technology
        15.7.4. By End-user
        15.7.5. By Country/Sub-region

16. Competition Landscape
    16.1. Market Player - Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. Illumina, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Thermo Fisher Scientific, Inc.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. Pacific Biosciences
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Complete Genomics Incorporated
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Vela Diagnostics
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Oxford Nanopore Technologies plc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Singular Genomics Systems, Inc.
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. HTG Molecular Diagnostics, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Revvity
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Next Generation Sequencers (NGS) Market Size, by Product, 2022

Figure 02: Global Next Generation Sequencers (NGS) Market Share (%), by Product, 2022

Figure 03: Global Next Generation Sequencers (NGS) Market Size, by Application, 2022

Figure 04: Global Next Generation Sequencers (NGS) Market Share (%), by Application, 2022

Figure 05: Global Next Generation Sequencers (NGS) Market Size, by Technology, 2022

Figure 06: Global Next Generation Sequencers (NGS) Market Share (%), by Technology, 2022

Figure 07: Global Next Generation Sequencers (NGS) Market Size, by End-user, 2022

Figure 08: Global Next Generation Sequencers (NGS) Market Share (%), by End-user, 2022

Figure 09: Global Next Generation Sequencers (NGS) Market, by Region (2022 and 2031)

Figure 10: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 12: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022

Figure 13: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2031

Figure 14: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023–2031

Figure 15: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 16: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022

Figure 17: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2031

Figure 18: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023–2031

Figure 19: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 20: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022

Figure 21: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2031

Figure 22: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023–2031

Figure 23: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 24: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 25: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2031

Figure 26: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023–2031

Figure 27: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031

Figure 28: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022

Figure 29: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2031

Figure 30: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Region, 2023–2031

Figure 31: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 32: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country, 2022 and 2031

Figure 33: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country, 2023–2031

Figure 34: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 35: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

Figure 36: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 37: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-31

Figure 38: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 39: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-31

Figure 40: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 41: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

Figure 42: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 43: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 44: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 45: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 46: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

Figure 47: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 48: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

Figure 49: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 50: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

Figure 51: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 52: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

Figure 53: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 54: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 55: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 57: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

Figure 58: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 59: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

Figure 60: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 61: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

Figure 62: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 63: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

Figure 64: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 65: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 66: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 67: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 68: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

Figure 69: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 70: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

Figure 71: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 72: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

Figure 73: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 74: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

Figure 75: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 76: Middle East & Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 77: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 78: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031

Figure 79: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031

Figure 80: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031

Figure 81: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031

Figure 82: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031

Figure 83: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031

Figure 84: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 85: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031

List of Tables

List of Tables

Table 01: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 03: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 04: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 05: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 06: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 07: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 08: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 09: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 10: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 11: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 12: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 13: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 14: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 15: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 16: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 17: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 18: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 19: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 20: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 23: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 25: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 26: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 27: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 28: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 29: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031

Table 30: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031